首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1813205

腦脊髓液 (CSF) 管理設備的全球市場:產品·年齡層·終端用戶·各地區 (～2027年)

Global Cerebrospinal Fluid Management Devices Market Research Report Information by Product, by Age Group, by End User, and by Region Forecast till 2027

出版日期: 2025年08月09日 | 出版商:

Market Research Future | 英文 142 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

產業概要

預計到 2027 年，全球腦脊髓液 (CSF) 管理設備市場規模將達到 38.2161 億美元，預測期內複合年增長率為 5.45%。

腦脊髓液管理設備有助於維持中樞神經系統的腦脊髓液平衡。透過引流或分流多餘的腦脊髓液，它們可以降低顱內壓，並在治療腦積水和創傷性腦損傷等疾病方面發揮重要作用。

全球老齡人口的成長是推動該市場成長的主要因素之一。此年齡層常見的與年齡相關的神經系統疾病包括阿茲海默症、帕金森氏症和中風。聯合國預測，到2050年，老年人口將達到4.25億，這將進一步增加醫療保健需求。這些人口結構變化可能會對腦脊髓液管理設備的需求產生最大影響。老年患者通常患有退化性疾病和合併症，這增加了對臨床幹預的需求。

區域分析

美洲市場在數量上領先全球，這得益於參與公司的大量資本投資、優質的醫院基礎設施以及眾多的研發項目。 2019年，北美市場銷售額為7.0599億美元，拉丁美洲市場銷售額為2.1313億美元。

歐洲市場競爭依然激烈，其中西歐佔最大佔有率。為了維持市場地位，各公司正專注於與醫生建立關係並實施針對特定產品的培訓計劃，這推動了設備採用率的提高。歐洲市場也表現強勁，西歐市場銷售額為5.4303億美元，東歐市場銷售額為1.548億美元。

亞太地區正成為一個充滿活力的市場，由於醫療保健支出的快速增長以及政府對研發的大力支持，其成長潛力巨大。該地區的學術會議和研討會是知識共享的催化劑。中國以1.9098億美元的市場規模領先，其次是日本（1.2510億美元）和印度（9,868萬美元）。

本報告探討了全球腦脊髓液 (CSF) 管理設備市場，包括市場定義和概述、影響市場成長的各種因素分析、市場規模趨勢和預測、按不同細分市場、地區和主要國家/地區進行的細分、競爭格局以及主要公司的概況。

Global Cerebrospinal Fluid Management Devices Market Research Report Information by Product (Shunts, Valve, Critical Care Products, Dural Sealants, Others), by Age Group (Pediatric, Adult, Geriatric), by End User (Hospitals, Ambulatory Settings, Research and Academic Institutes, Others), and by Region (Americas, Europe, Asia-Pacific, Middle East & Africa) Forecast till 2027

Industry Overview

The global cerebrospinal fluid management devices market is expected to achieve a value of USD 3,821.61 million by 2027, expanding at a 5.45% CAGR by the end of 2027. Cerebrospinal fluid management devices help maintain the balance of CSF within the central nervous system. By draining or diverting excess fluid, these devices reduce intracranial pressure and are vital for treating conditions like hydrocephalus and traumatic brain injury.

The increase in the elderly population globally is among the main factors that have contributed to the growth of the cerebrospinal fluid management devices market. The age-related neurological disorders that are also generally healthy in this group of people include Alzheimer's disease, Parkinson's, and stroke. The United Nations predicts that the number of elderly will rise to 425 million by 2050, which will mean higher healthcare needs. Such an evolution of the demographic structure is expected to have the most profound effect on the demand for CSF management devices, as the elderly in general are the least healthy with degenerative diseases and complications requiring clinical intervention.

Major Company Development

In October 2017, Natus Medical Incorporated took over the neurosurgical product line of Integra LifeSciences to supplement its product offerings. The deal amounted to the acquisition of the Camino ICP monitoring line, US rights to fixed pressure shunts, CSF collection systems, Codman's DURAFORM dural graft implant, and standard EVD catheters, among others. Through the union of these products, Natus widened its knowledge base in neurological care and strengthened its competitive position. The strategic move was aimed at accelerating growth and strengthening the company's presence in the global cerebrospinal fluid management devices market.

Key Players

Major players in the global cerebrospinal fluid management devices market are Medtronic PLC, Natus Medical Incorporated, B. Braun Melsungen AG, Sophysa, IRRAS AB, Moller Medical GmbH, Argi Grup, Longeviti, Integra LifeSciences, Corporation, and Anuncia.

Report Attribute Details

Market Size 2019: USD 2,505.13 Million
Market Size 2027: USD 3,821.61Million
CAGR (2020-2027): 5.45%
Base Year: 2019
Market Forecast Period: 2020-2027

Industry Segmentations

By Product: Shunts - 5.26%, Critical Care Products - 5.44%.
By Age Group: Pediatric - 5.30%, Adult - 5.67%.
By End User: Hospitals - 5.41%, Ambulatory Settings - 5.71%.

Regional Analysis

The CSF management devices market in the Americas leads in volume, which is supported by the presence of industry players with huge capital investments, good hospital infrastructure, and a significant number of R&D projects. In 2019, North America generated USD 705.99 million, complemented by USD 213.13 million from Latin America.

Europe is still a competitive market that drives innovation, and it is mainly the Western part of Europe that has the largest share. To keep their position, companies concentrate on staff-surgeon relations and product-specific training programs, which creates higher usage of implantable devices for CSF management. Europe posted notable figures, with Western Europe contributing USD 543.03 million and Eastern Europe adding USD 154.80 million.

The Asia-Pacific area is becoming a highly dynamic market and is likely to be a region of high potential with soaring healthcare spending and a strong government support for R&D. The organizations and conferences in the region act as the brakes on the machine of knowledge exchange. China led at USD 190.98 million, while Japan and India followed with USD 125.10 million and USD 98.68 million.

The Middle East & Africa market is still in its developmental stage, yet it holds long-term promise with increasing hospital expansions and growing collaborations. GCC nations are actively investing in healthcare modernization, encouraging partnerships with multinational companies.

1 EXECUTIVE SUMMARY

1.1 OVERVIEW
1.2 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
- 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF HYDROCEPHALUS & SUBSEQUENT RISE IN NUMBER OF SHUNTING PROCEDURES
- 4.2.2 GROWING GERIATRIC POPULATION
4.3 RESTRAINT
- 4.3.1 COMPLICATIONS RELATED TO CSF SHUNT SYSTEMS
4.4 OPPORTUNITY
- 4.4.1 ENTERING DEVELOPING MARKETS
4.5 COVID-19 IMPACT ANALYSIS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D AND DESIGNING
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION
- 5.1.4 MARKETING AND SALES
- 5.1.5 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 BARGAINING POWER OF BUYERS
- 5.2.4 THREAT OF SUBSTITUTES
- 5.2.5 INTENSITY OF RIVALRY

6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 SHUNTS
6.3 CRITICAL CARE PRODUCTS
6.4 DURAL SEALANTS
6.5 OTHERS

7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP

7.1 OVERVIEW
7.2 PEDIATRIC
7.3 ADULT
7.4 GERIATRIC

8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS
8.3 AMBULATORY SETTINGS
8.4 RESEARCH & ACADEMIC INSTITUTES

9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION

9.1 OVERVIEW
9.2 AMERICAS
- 9.2.1 NORTH AMERICA
  - 9.2.1.1 US
  - 9.2.1.2 CANADA
- 9.2.2 LATIN AMERICA
9.3 EUROPE
- 9.3.1 WESTERN EUROPE
  - 9.3.1.1 GERMANY
  - 9.3.1.2 FRANCE
  - 9.3.1.3 REST OF WESTERN EUROPE
  - 9.3.1.4 UK
  - 9.3.1.5 ITALY
  - 9.3.1.6 SPAIN
- 9.3.2 EASTERN EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 JAPAN
- 9.4.3 REST OF ASIA PACIFIC
- 9.4.4 INDIA
- 9.4.5 SOUTH KOREA
- 9.4.6 AUSTRALIA
9.5 MIDDLE EAST & AFRICA
- 9.5.1 MIDDLE EAST
- 9.5.2 AFRICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 ACQUISITION ACTIVITIES
- 10.6.2 EXPANSIONS
- 10.6.3 PRODUCT LAUNCHES
10.7 FINANCIAL MATRIX
- 10.7.1 SALES
- 10.7.2 R&D EXPENDITURE

11 COMPANY PROFILES

11.1 MEDTRONIC PLC
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS/SERVICES OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 NATUS MEDICAL INCORPORATED
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS/SERVICES OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 B. BRAUN MELSUNGEN AG
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS/SERVICES OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 SOPHYSA
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS/SERVICES OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 SWOT ANALYSIS
- 11.4.6 KEY STRATEGIES
11.5 IRRAS AB
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS/SERVICES OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
11.6 MOLLER MEDICAL GMBH
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS/SERVICES OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
11.7 ARGI GRUP
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS/SERVICES OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 LONGEVITI
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS/SERVICES OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 INTEGRA LIFESCIENCES CORPORATION
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS/SERVICES OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 SWOT ANALYSIS
- 11.9.6 KEY STRATEGIES
11.10 ANUNCIA
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS/SERVICES OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 SWOT ANALYSIS
- 11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES
12.2 RELATED REPORTS

簡介目錄圖表

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2017-2027 (USD MILLION)
TABLE 3 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS, BY REGION 2017-2027 (USD MILLION)
TABLE 4 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 5 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 6 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCTS, BY REGION 2017-2027 (USD MILLION)
TABLE 7 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCTS, BY TYPE 2017-2027 (USD MILLION)
TABLE 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR DURAL SEALANTS, BY REGION 2017-2027 (USD MILLION)
TABLE 10 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2017-2027 (USD MILLION)
TABLE 11 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR PEDIATRIC, BY REGION 2017-2027 (USD MILLION)
TABLE 12 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR ADULT, BY REGION 2017-2027 (USD MILLION)
TABLE 13 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR GERIATRIC, BY REGION 2017-2027 (USD MILLION)
TABLE 14 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2017-2027 (USD MILLION)
TABLE 15 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR HOSPITALS, BY REGION 2017-2027 (USD MILLION)
TABLE 16 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR AMBULATORY SETTINGS, BY REGION 2017-2027 (USD MILLION)
TABLE 17 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION 2017-2027 (USD MILLION)
TABLE 18 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION, 2019 (%)
TABLE 19 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2017-2027 (USD MILLION)
TABLE 20 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 21 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 22 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 23 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 24 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 25 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 26 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 27 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 28 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 29 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 30 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 31 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 32 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 33 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 34 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 35 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 36 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 37 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 38 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 39 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 40 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 41 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 42 US: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 43 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 44 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 45 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 46 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 47 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 48 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 49 CANADA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 50 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 51 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 52 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 53 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 54 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 55 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 56 LATIN AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 57 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 58 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 59 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 60 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 61 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 62 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 63 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 64 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 65 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY 2017-2027 (USD MILLION)
TABLE 66 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 67 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 68 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 69 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 70 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 71 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 72 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 73 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 74 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 75 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 76 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 77 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 78 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 79 GERMANY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 80 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 81 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 82 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 83 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 84 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 85 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 86 FRANCE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 87 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 88 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 89 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 90 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 91 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 92 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 93 REST OF WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 94 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 95 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 96 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 97 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 98 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 99 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 100 UK: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 101 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 102 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 103 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 104 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 105 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 106 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 107 ITALY: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 108 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 109 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 110 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 111 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 112 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 113 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 114 SPAIN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 115 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 116 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 117 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 118 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 119 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 120 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 121 EASTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 122 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 123 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 124 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 125 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 126 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 127 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 128 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 129 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 130 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 131 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 132 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 133 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 134 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 135 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 136 CHINA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 137 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 138 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 139 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 140 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 141 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 142 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 143 JAPAN: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 144 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 145 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 146 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 147 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 148 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 149 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 150 REST OF ASIA PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 151 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 152 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 153 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 154 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 155 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 156 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 157 INDIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 158 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 159 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 160 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 161 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 162 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 163 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 164 SOUTH KOREA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 165 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 166 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 167 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 168 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 169 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 170 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 171 AUSTRALIA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 173 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 174 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 175 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 176 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 180 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 181 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 182 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 183 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 184 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 185 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 186 MIDDLE EAST: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 187 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT, 2017-2027 (USD MILLION)
TABLE 188 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR SHUNTS SYSTEM, BY TYPE 2017-2027 (USD MILLION)
TABLE 189 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR VALVE MECHANISM, BY TYPE 2017-2027 (USD MILLION)
TABLE 190 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR CRITICAL CARE PRODUCT, BY TYPE 2017-2027 (USD MILLION)
TABLE 191 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, FOR EXTERNAL DRAINAGE SYSTEMS, BY TYPE 2017-2027 (USD MILLION)
TABLE 192 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP, 2017-2027 (USD MILLION)
TABLE 193 AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 194 BENCHMARKING OF MAJOR COMPETITORS
TABLE 195 ACTIVE PLAYERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
TABLE 196 ACQUISITION ACTIVITIES
TABLE 197 EXPANSIONS
TABLE 198 PRODUCT LAUNCHES
TABLE 199 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED
TABLE 200 NATUS MEDICAL INCORPORATED: PRODUCTS/SERVICES OFFERED
TABLE 201 NATUS MEDICAL INCORPORATED: KEY DEVELOPMENTS
TABLE 202 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED
TABLE 203 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS
TABLE 204 SOPHYSA: PRODUCTS/SERVICES OFFERED
TABLE 205 IRRAS AB: PRODUCTS/SERVICES OFFERED
TABLE 206 IRRAS AB: KEY DEVELOPMENTS
TABLE 207 MOLLER MEDICAL GMBH: PRODUCTS/SERVICES OFFERED
TABLE 208 ARGI GRUP: PRODUCTS/SERVICES OFFERED
TABLE 209 LONGEVITI: PRODUCTS/SERVICES OFFERED
TABLE 210 LONGEVITI: KEY DEVELOPMENTS
TABLE 211 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 212 INTEGRA LIFESCIENCES CORPORATION: KEY DEVELOPMENTS
TABLE 213 ANUNCIA: PRODUCTS/SERVICES OFFERED
TABLE 214 ANUNCIA: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
FIGURE 4 DRIVER IMPACT ANALYSIS
FIGURE 5 RESTRAINT IMPACT ANALYSIS
FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
FIGURE 8 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2019 (%)
FIGURE 9 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY PRODUCT 2019 & 2027 (USD MILLION)
FIGURE 10 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2019 (%)
FIGURE 11 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY AGE GROUP 2019 & 2027 (USD MILLION)
FIGURE 12 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2019 (%)
FIGURE 13 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY END USER 2019 & 2027 (USD MILLION)
FIGURE 14 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 & 2027 (USD MILLION)
FIGURE 15 AMERICAS: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%)
FIGURE 16 NORTH AMERICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY COUNTRY 2019 (%)
FIGURE 17 EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%)
FIGURE 18 WESTERN EUROPE: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY COUNTRY 2019 (%)
FIGURE 19 ASIA-PACIFIC: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%)
FIGURE 20 MIDDLE EAST & AFRICA: CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET SHARE, BY REGION 2019 (%)
FIGURE 21 MAJOR MANUFACTURERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, MARKET SHARE (2019)
FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET
FIGURE 23 GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, COMPETITIVE LANDSCAPE
FIGURE 24 SALES
FIGURE 25 R&D EXPENDITURE
FIGURE 26 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MEDTRONIC PLC: SWOT ANALYSIS
FIGURE 28 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS
FIGURE 30 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW
FIGURE 31 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
FIGURE 32 SOPHYSA: SWOT ANALYSIS
FIGURE 33 IRRAS AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 IRRAS AB: SWOT ANALYSIS
FIGURE 35 MOLLER MEDICAL GMBH: SWOT ANALYSIS
FIGURE 36 ARGI GRUP: SWOT ANALYSIS
FIGURE 37 LONGEVITI: SWOT ANALYSIS
FIGURE 38 INTEGRA LIFESCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 INTEGRA LIFESCIENCES CORPORATION: SWOT ANALYSIS
FIGURE 40 ANUNCIA: SWOT ANALYSIS